Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Jul 26, 2016, after the close
10-Q filed Aug 4, 2016, 35 days after period end · 0001193125-16-672054
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.00M | -$8.96M | -$5.85M | -$4.45M |
| EPS Diluted |
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
| -$2.25 |
| -$0.40 |
| -$11.68 |
| -$12.95 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.